Repaglinide and Cephalexin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repaglinide (repaglinide) and Cephalexin (cephalexin). Common drug interactions include chronic kidney disease among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Repaglinide and Cephalexin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

On Jul, 27, 2026

26 people who take Repaglinide and Cephalexin together, and have interactions are studied.

Repaglinide and Cephalexin drug interactions.

What are the common drug interactions of Repaglinide and Cephalexin, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Nephrogenic anaemia (anaemia due to kidney disease)
Dyspepsia (indigestion)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Cardiac failure congestive
Death

male:

Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Death
Decreased appetite
Weight decreased
Anxiety
Chronic kidney disease
Emotional distress
Gout (uric acid crystals building up in the body)

What are the common drug interactions of Repaglinide and Cephalexin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Epigastric discomfort
Gastritis (inflammation of stomach)
Acute respiratory distress syndrome
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Cardiac failure congestive
Chronic kidney disease
Coma (state of unconsciousness lasting more than six hours)
Drug clearance decreased
Feeding disorder (when children refuse to eat certain food groups)
Nasopharyngitis (inflammation of the nasopharynx)

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Death
Dyspepsia (indigestion)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperkalaemia (damage to or disease of the kidney)

60+:

Anaemia (lack of blood)
Chronic kidney disease
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Atrioventricular block first degree (heart block first degree)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Fatigue (feeling of tiredness)
Folliculitis (infection of hair root)
Haemoglobin decreased
Loss of consciousness
Macroangiopathy (a disease of the large blood vessels in which fat and blood clots build up and stick to the vessel walls, blocking the flow of blood)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 30.77%
Nausea (feeling of having an urge to vomit): 3 people, 11.54%
High Blood Cholesterol: 3 people, 11.54%
Depression: 3 people, 11.54%
Constipation: 3 people, 11.54%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.69%
Pain: 2 people, 7.69%
Multiple Myeloma (cancer of the plasma cells): 2 people, 7.69%
Ill-Defined Disorder: 2 people, 7.69%
Hiv Infection: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and Cephalexin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously